Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study

To compare the risk of urolithiasis in gout patients initiating allopurinol, a xanthine oxidase inhibitor, vs benzbromarone, a uricosuric. Using the 2011-20 Korea National Health Insurance Service database, we conducted a cohort study on gout patients initiating allopurinol vs benzbromarone as the f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology (Oxford, England) England), 2024-09, Vol.63 (9), p.2433-2441
Hauptverfasser:	Kang, Eun Ha, Shin, Anna, Park, Chang Soo, Lee, Eun Bong, Lee, Yun Jong, Curhan, Gary, Choi, Hyon K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Allopurinol - adverse effects Allopurinol - therapeutic use Benzbromarone - adverse effects Benzbromarone - therapeutic use Cohort Studies Female Gout - drug therapy Gout Suppressants - adverse effects Gout Suppressants - therapeutic use Humans Incidence Male Middle Aged Proportional Hazards Models Republic of Korea - epidemiology Risk Factors Uricosuric Agents - therapeutic use Urolithiasis - chemically induced Urolithiasis - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!